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SUMMARY
While adverse effects of prolonged recipient warm ischemia time (rWIT)
in liver transplantation (LT) have been well investigated, few studies have
focused on possible positive prognostic effects of short rWIT. We aim to
investigate if shortening rWIT can further improve outcomes in donation
after brain death liver transplant (DBD-LT). Primary DBD-LT between
2000 and 2019 were retrospectively reviewed. Patients were divided according to rWIT (≤30, 31–40, 41–50, and >50 min). The requirement of intraoperative transfusion, early allograft dysfunction (EAD), and graft survival
were compared between the rWIT groups. A total of 1,256 patients of
DBD-LTs were eligible. rWIT was ≤30min in 203 patients (15.7%), 31–
40min in 465 patients (37.3%), 41–50min in 353 patients (28.1%), and
>50min in 240 patients (19.1%). There were significant increasing trends
of transfusion requirement (P < 0.001) and increased estimated blood loss
(EBL, P < 0.001), and higher lactate level (P < 0.001) with prolongation of
rWIT. Multivariable logistic regression demonstrated the lowest risk of
EAD in the WIT ≤30min group. After risk adjustment, patients with rWIT
≤30 min showed a significantly lower risk of graft loss at 1 and 5-years,
compared to other groups. The positive prognostic impact of rWIT
≤30min was more prominent when cold ischemia time exceeded 6 h. In
conclusion, shorter rWIT in DBD-LT provided significantly better posttransplant outcomes.
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Introduction
In solid organ transplantation, ischemia-reperfusion
injury of the graft is inevitable. Several studies have
investigated the effects of ischemia damage on graft
function and outcomes in liver transplantation (LT)
and sought to identify the medical and surgical strategies to mitigate the adverse impact of such damage [1].
In LT, graft ischemia times comprise cold ischemia time
(CIT) and warm ischemia time (WIT). Cold ischemia
ª 2021 Steunstichting ESOT. Published by John Wiley & Sons Ltd
doi:10.1111/tri.13962

time is defined as the time between donor crossclamping (and flushing), and the removal of the liver
from cold preservation solution immediately before
implantation. In donation after brain death donor
(DBD) LTs, the only WIT is recipient WIT (rWIT),
which is defined as the time between the removal of the
liver from cold preservation solution to portal reperfusion. On the other hand, in donation after circulatory
death donor (DCD) LTs, WIT occurs both in donor
and recipient surgeries. WIT in DCD donor surgery is
1
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typically defined as the time between donor extubation
and cross-clamping [2]. A variety of strategies, such as
normothermic regional perfusion of the liver graft for
DCD donors, have been proposed and utilized to alleviate the negative effects of donor WIT. However, rWIT,
essentially equivalent to “liver graft implantation time”,
might be considered “fixed-time”. In other words, it
would not allow for much improvement given that
modern LT surgical techniques are already generally
well sophisticated.
Warm ischemia of the liver graft is more deleterious
to hepatocytes and high energy demands begin at 20⁰C
of the liver core temperature [3]. It has been well
reported that prolonged rWIT is associated with poor
LT outcomes [4–6]. Rana et al. reported that rWIT of
60 min or longer, compared to less than 60 min, was
significantly associated with worse 3–months patient
survival [7]. Typically, rWIT ranges between 30–50 min,
which is usually considered as an “acceptable length” of
rWIT [6–9]. However, it has not been well studied
whether keeping rWIT shorter than the acceptable time,
more specifically within 30 min, could lead to further
improvement in LT outcomes.
In this study, we focused on the prognostic impact of
rWIT in DBD-LT and hypothesized that further
improvement of outcomes can be achieved by shortening rWIT liver graft implantation time in DBD-LT. This
study aimed to assess the prognostic impact of rWIT on
DBD-LT outcomes by primarily focusing on possible
positive prognostic effects of short rWIT.

Methods
Study population
Our institution’s prospective maintained transplant surgery database was retrospectively queried to identify
patients who underwent LT between January 2000 and
September 2019. Patients undergoing primary LT from
DBD donors were included. Exclusion criteria included
transplantation from DCD donors, patients undergoing
retransplantation, simultaneous multi-organ transplantation, and living donor LT. Our Institutional Review
Board approved the investigation.

Surgical management
Donor livers were flushed in situ with histidinetryptophan-ketoglutarate (HTK) or University of Wisconsin (UW) solution, and the portal flush was added
on the back table. Note that the preferred preservation
2

solution at our center and transplant region is HTK;
however, we do occasionally receive livers imported
from regions that utilize a UW flush. The hepatic
venous outflow reconstruction selected during the LT
depended on intraoperative factors and surgeon preference, and was either piggyback or bicaval technique.
Portal reperfusion was performed prior to arterial reperfusion in all cases. CIT was defined as the time between
donor cross-clamping and the removal of the liver from
cold preservation solution immediately before implantation. rWIT was defined as the time between removing
the liver from cold preservation solution to portal
reperfusion (namely, the time required to complete
caval and portal venous anastomosis ). This was followed by the completion of the hepatic arterial anastomosis.

Post-transplant management
All patients were transferred postoperatively to the surgical intensive care unit, followed by transfer to the
Transplant Surgery unit, and regular clinical and laboratory follow-up occurred. Postoperative maintenance
immunosuppression with tacrolimus, mycophenolate
mofetil, and steroids was utilized.

Analysis of post-transplant outcomes
The patients were categorized according to rWIT: ≤ 30,
31–40, 41–50, and >50 min. Primary outcomes evaluated were graft and patient survival, which were compared among the rWIT subcategories. The hazards of
graft loss were adjusted for the following variables.
Recipient variables included age, gender, ethnicity, body
mass index (BMI), diabetes, Karnofsky Score, etiology
of liver disease, model for end-stage liver disease
(MELD) score at transplant, cold ischemia time (CIT),
dialysis requirement, presence of ascites and hepatic
encephalopathy, hepatic vein reconstruction techniques
(piggyback vs. bicaval), and the era of transplantation
(2000–2004, 2005–2010, 2011–2014, 2015–2019). Donor
variables included age, gender, and BMI. The effects of
rWIT on graft survival were further evaluated after
stratification by CIT (≤6 and >6 hours).
The secondary outcomes assessed were intraoperative
transfusion requirement and post-transplant early allograft dysfunction (EAD)[10]. Our institutional database
includes EAD data for all LTs performed after January
1, 2012. The hazards of EAD were adjusted for the following recipient and donor characteristics: age, gender,
ethnicity, body mass index (BMI), diabetes, Karnofsky
Transplant International 2021;
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Score, dialysis requirement, presence of ascites and hepatic encephalopathy, era of transplantation, and donor
risk index (DRI)[11].
To investigate the direct and indirect effects of rWIT
on the occurrence of EAD and graft loss, mediation
analysis were conducted. The exposure variable (rWIT)
can have a direct effect on outcomes such as EAD and
graft loss. Intraoperative blood loss may be a risk factor
for EAD and/or graft loss as well. The association
between rWIT and endpoints (EAD, graft loss) might
be mediated by intraoperative blood loss. The direct
and indirect effects of rWIT on the endpoints were
assessed using causal mediation analysis. The total
amount of packed red blood cell transfusion and autologous transfusion during LT surgery was used as a substitute for intraoperative blood loss.

Statistical analysis
Descriptive data for continuous variables were reported
as mean (standard deviation) or median with
interquartile range and compared using the student’s ttest and Kruskal–Wallis test. Categorical variables were
reported as numbers and percentages and were compared using chi-square. Trends of values according to
rWIT were assessed using the Jonckheere-Terpstra test.
Graft and patient survival were analyzed using the
Kaplan-Meier method, and the subgroups compared
using log-rank tests. Trends of survival according to
rWIT were checked using the log-rank trend test. Cox
proportional hazard regression models were constructed
to identify predictors for post- LT graft loss. Similarly,
predictors of EAD were evaluated using a logistic
regression model. Regression with a backward model
selection was considered to determine risk factors for
graft loss and the occurrence of EAD. Mediation analysis was performed using PROCESS v3.4.1 created by
Preacher and Hayes. A P-value <0.05 was considered
statistically significant. All statistical analyses were performed using SPSS version 25 (IBM Corp., Armonk,
NY).

Results
During the study period, 1,815 LTs were performed, of
which 1,290 patients met the inclusion criteria. rWIT
data were available for 1,261 patients. This included 203
patients (15.7%) with a rWIT ≤ 30 min, 465 patients
(36%) with a rWIT 31–40 min, 353 patients (27.4%)
with a rWIT 41–50 min, and 240 patients (18.6%) with
a rWIT >50 min. Mean rWIT was 48.6 min in the years
Transplant International 2021;
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2000–2004, 44.2 min in 2005–2010, 38.0 min in 2011–
2014, and 38.2 min in 2015–2019. The mean rWIT was
45.4 min in LTs performed before 2011 and 37.9 min
in LTs performed after January 1, 2011 (P < 0.001).
Baseline recipient, donor, and intraoperative characteristics are shown in Table 1. There were significant differences in the choice of hepatic vein implantation
technique. While the inferior vena cava (IVC)-sparing
technique was used in 96.6% in the group of rWIT ≤
30 min, this was used in 62.1% in the group of rWIT
>50 min (P < 0.001). The likelihood of achieving rWIT
≤ 30 min was 8 folds higher in the IVC-sparing technique (piggyback) compared to the bicaval technique
(odds ratio 8.22, 95%CI: 3.77–17.51, P < 0.001).

Intraoperative factors and rWIT
Table 2 demonstrates comparisons of median intraoperative transfusion requirements, blood loss, INR (international normalized ratio), and lactate levels at the end of
LT surgeries between the rWIT groups. There was a significant difference in all types of transfusion requirements, EBL, and median lactate level, according to rWIT.
The trend of transfusion requirement, EBL, and lactate
levels in an association with length of rWIT was checked
by the Jonckheere-Terpstra test, which demonstrated that
there were significant increasing trends of transfusion of
packed red blood cells (PRBC) requirement (PRBC,
P < 0.001; autologous transfusion, P < 0.001; cryoprecipitate, P < 0.001; FFP (fresh frozen plasma), P < 0.001;
platelet, P < 0.001), EBL (P < 0.001), and lactate level
(P < 0.001) with prolongation of rWIT.

EAD and rWIT
EAD data was available for transplants performed since
2012 (n = 431). Overall, EAD occurred in 106 patients
(24.6%). This included 20/111 (18.0%) of patients with
rWIT ≤ 30 min, 32/170 (18.8%) of those with rWIT 31–
40 min, 31/104 (29.8%) of those with rWIT 41–50 min,
and 23/46 (50.0%) of those with rWIT > 50 min
(P < 0.001). Multivariable logistic regression demonstrated a significantly higher risk of EAD in the groups
of WIT 41–50 min (P = 0.029, HR 2.2 [1.1–4.5]), and
WIT >50 min (P < 0.001, odds ratio 6.3 [2.7–14.8]) to
EAD, compared to WIT ≤ 30 min (Fig. S1).

Graft loss and mortality
Log-rank tests showed a statistically significant 5-year
graft and patient survival benefit when comparing rWIT
3
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Table 1. Baseline recipient and donor characteristics according to recipient warm ischemia time.
rWIT
Recipient factors
Age (year), mean  SD
Age group (%)
≤50
51–60
61–70
>70
Gender (male) (%)
Ethnicity (black), number (%)
BMI, mean  SD
Laboratory MELD (MELD-Na) score
at transplant, mean  SD
Comorbidities (%)
DM
Hyperlipidemia
HTN
CVA
CAD
Primary liver disease (%)
Hepatitis C
Alcohol
NASH
AIH
PSC
PBC
Acute liver failure
HCC (%)
Karnofsky score (%) 10%–30%
Grade 3 or 4 hepatic
encephalopathy (%)
Dialysis (%)
Moderate/severe ascites (%)
Donor and surgical factors
Age (year), mean  SD
Gender (male), number (%)
Ethnicity (Black) number (%)
BMI, mean  SD
CIT (hours), mean  SD
CIT > 6 hours (%)
IVC-sparing hepatic vein
reconstruction* (%)

≤30 min
(n = 203)

31–40 min
(n = 465)

41–50 min
(n = 353)

>50 min
(n = 240)

55.6  10.4

54.8  9.2

55.2  9.4

53.2  9.7

0.04

49 (24.1)
71 (35.0)
74 (36.5)
9 (4.4)
119 (58.6)
26 (12.8)
28.8  5.2
21.1  9.8

101 (21.7)
212 (45.6)
146 (31.4)
6 (1.3)
305 (65.6)
75 (16.1)
29.2  6.0
21.0  9.5

72 (20.4)
163 (46.2)
110 (31.2)
8 (2.3)
234 (66.3)
51 (14.4)
29.5  5.8
20.1  8.6

76 (31.7)
105 (43.8)
54 (22.5)
5 (2.1)
168 (70.0)
49 (20.4)
29.2  5.8
19.6  8.6

0.09
0.13
0.58
0.20

51 (25.1)
29 (15.6)
69 (37.1)
5 (2.7)
21 (11.4)

104 (22.4)
53 (12.4)
171 (40.1)
13 (3.3)
32 (8.0)

76 (21.6)
29 (9.0)
129 (40.1)
6 (2.0)
24 (8.2)

64 (26.8)
19 (8.8)
81 (37.5)
9 (4.8)
18 (9.6)

0.43
0.07
0.83
0.37
0.55

77 (38.1)
60 (29.7)
27 (13.4)
10 (5.0)
11 (5.4)
5 (2.5)
4 (2.0)
59 (29.2)
31 (15.7)
25 (12.8)

203 (43.7)
155 (33.3)
44 (9.5)
11 (2.4)
26 (5.6)
18 (3.9)
10 (2.2)
129 (27.7)
67 (14.8)
60 (13.5)

156 (44.2)
103 (29.2)
32 (9.1)
8 (2.3)
21 (5.9)
14 (4.0)
7 (2.0)
106 (30.0)
35 (10.3)
33 (10.1)

101 (42.1)
63 (26.2)
21 (8.8)
7 (2.9)
20 (8.3)
6 (2.5)
11 (4.6)
56 (23.3)
21 (9.3)
16 (8.1)

0.52
0.25
0.33
0.26
0.49
0.62
0.17
0.33
0.056
0.17

15 (7.4)
57 (29.2)

25 (5.4)
135 (30.3)

17 (4.8)
82 (25.0)

9 (3.8)
51 (25.8)

0.38
0.35

44.5  16.9
102 (50.2)
44 (21.7)
28.2  7.0
5.4  1.4
51 (25.1)
196 (96.6)

43.1  16.8
254 (54.6)
83 (17.8)
27.9  6.7
5.6  1.4
154 (33.2)
408 (87.7)

45.4  16.2
203 (57.5)
71 (20.1)
28.1  6.4
5.9  1.8
147 (42.1)
263 (74.5)

43.1  16.5
150 (62.5)
46 (19.2)
28.6  7.0
6.16  1.7
116 (48.3)
149 (62.1)

P value

0.17
0.057
0.68
0.62
<0.001
<0.001
<0.001

AIH, autoimmune hepatitis; ALF, acute liver failure; BMI, body mass index; CAD, coronary artery disease; CIT, cold ischemia time;
CVA, cerebrovascular accident; DM, diabetes mellites; HCC, hepatocellular carcinoma; HTN, hypertension; MELD, Model for EndStage Liver Disease; NASH, nonalcoholic steatohepatitis; PBC, primary biliary cirrhosis; PSC, primary sclerosing cholangitis.
*Piggyback or cavocavostomy technique.

≤ 30 min to all other rWIT subgroups (Fig. 1). rWIT ≤
30 min provided significant 1-year graft survival compared to rWIT 41–50 min and rWIT >50 min, and significant 1-year patient survival compared to rWIT >
50 min. Log-rank trend tests showed that decreasing
4

trends of 1 and 5-year graft survival rates with increasing rWIT were significant (P < 0.001 and 0.003, respectively).
After risk adjustment, patients with rWIT ≤ 30 min
maintained a significantly lower risk of graft loss at 1
Transplant International 2021;
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Table 2. Comparisons of intraoperative factors according to recipient warm ischemia time.
rWIT

≤30 min
(n = 203)

31–40 min
(n = 465)

EBL (mL),
1500 [1000, 2550] 1900 [1000, 3000]
median (IQR)
Transfusion
PRBC (unit),
3.0 [1.0, 6.0]
3.0 [1.0, 6.0]
median (IQR)
Autologous (unit),
2.0 [1.0, 3.0]
2.0 [1.0, 4.0]
median (IQR)
1.00 [0, 3.0]
0 [0, 5.0]
Cryoprecipitate
(unit),
median (IQR)
FFP (unit),
5.0 [2.0, 9.0]
6.0 [3.0, 10.0]
median (IQR)
Platelet (unit),
0 [0, 2.0]
0 [0, 6.0]
median (IQR)
2.10 [1.83, 2.58]
2.08 [1.77, 2.44]
INR at end of
surgery,
median (IQR)
2.40 [1.80, 3.88]
3.60 [2.00, 5.80]
Lactate at
end of surgery,
median (IQR)

P value*

P value
for trend†

2000 [1200, 4000] 2675 [1500, 5525]

<0.001

<0.001

3.00 [1.0, 6.0]

4.00 [2.0, 8.0]

<0.001

<0.001

3.0 [1.0, 5.0]

3.0 [2.0, 7.0]

<0.001

<0.001

0.5 [0.0, 10.0]

3.0 [0.0, 10.0]

<0.001

<0.001

6.0 [4.0, 11.0]

8.0 [4.0, 13.0]

<0.001

<0.001

1.0 [0, 6.0]

5.0 [0, 10.0]

<0.001

<0.001

41–50 min
(n = 353)

>50 min
(n = 240)

2.20 [2.00, 2.51]

2.06 [1.74, 2.41]

0.26

0.46

4.25 [2.62, 6.57]

5.00 [2.73, 7.58]

<0.001

<0.001

EBL, estimated blood loss; FFP, fresh frozen plasma; PRBC, packed red blood cells.
*Kruskal–Wallis test.
†

Jonckheere-Terpstra test.

and 5- years. The risk of 1-year graft loss was significantly lower in the groups of rWIT ≤30min, compared
to 31–40min (HR 0.45, 95%CI: 0.23–0.90, P = 0.02),
41–50min (HR 0.43, 95%CI: 0.21–0.88, P = 0.02), and
>50min (HR 0.27, 95%CI: 0.13–0.55, P < 0.001)
(Fig. 2a). Similar findings were observed when assessing
the risk of 5-year graft loss (Fig. 2b). There was no significant difference when comparing the risk between the
three groups (31–40 min vs. 41–50 min vs. >50 min).
Table 3 presents the final multivariable Cox regression
model with a backward selection for 1 and 5-year graft
loss. Independent risk factors for 1-year graft loss
included recipient BMI >30 (ref. BMI 25–30), Grade 3
or 4 encephalopathy, Karnofsky score 10–30%, MELD
score, acute liver failure as primary liver disease, cold
ischemia time, and female donor, along with rWIT.
Independent risk factors for 5-year graft loss included
Grade 3 or 4 encephalopathy, acute liver failure as primary liver disease, and the presence of hepatocellular
carcinoma, and older donor age, along with rWIT.

Prognostic impact of rWIT in association with CIT
Cold ischemia time was an independent risk factor for
graft loss. A threshold to stratify the risk was a CIT of
Transplant International 2021;
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6 hours (Fig. S2). Because CIT and rWIT might have
synergistic effects on outcomes, the impact of rWIT was
assessed by stratifying the cohort of patients into CIT:
≤6 hours and >6 hours. The protective effect of rWIT
≤30 min from graft loss was more pronounced in the
subgroup of patients with a CIT of greater than 6 hours
(Fig. S3). In the longer CIT group, the shortest rWIT
group showed a lower risk of graft loss at 1 and 5years, compared with rWIT 31–40 min, 41–50 min, and
>50 min. In the shorter CIT group, the difference of
risk was significant between the shortest and longest
rWIT groups (≤30min vs. >50min), but the risk was
similar between the shortest group and the groups of
31–40min or 41–50min (Fig. 3).
Of note, we evaluated the positive effect of short
rWIT according to different CIT cut-offs. There were
only 82 and 21 patients who had CIT of 8–10 hours
and 10 hours or longer, respectively. When comparing
1-year graft survival rates in the group with CIT of
8 hours or longer according to rWIT, 1-year graft survival rates were 90% (n = 27), 82.1% (n = 39), 77.3%
(n = 27), and 74.1% (n = 10) in those with rWIT of
30 min or shorter, 31–40 min, 41–50 min, and
>50 min, respectively (P = 0.778). While the difference
did not reach statistical significance, likely due to the
5
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Figure 1 Graft and patient survival according to recipient warm ischemia time.

Figure 2 Adjusted hazards of 1 and 5-year graft loss in the group of recipient warm ischemia time of 30 min or shorter.

small number of patients, we still observed a trend
towards superior outcomes in the shorter rWIT group.

Mediation analysis
Mediation analysis demonstrated a significant direct
positive effect of shorter rWIT on graft outcome, compared to rWIT >50 min (Effect –0.517 [95% CI:
1.032, 0.001], P = 0.050). It also showed significant
indirect effects of shorter rWIT on graft outcome via
intraoperative blood loss (≤30 min: Effect –0.121 [95%
CI: –0.234, 0.035]), 31–40 min: Effect –0.096 [95%
CI: –0.198, 0.025], 41–50 min: Effect –0.074 [95% CI:
6

–0.163, 0.015]) (ref. rWIT >50 min) (Fig. 4a). Shorter
rWIT had a significant direct effect on occurrence of
EAD when comparing rWIT > 50 min to both rWIT
≤30 min (Effect –1.328 [95% CI: –2.124,
0.531],
P = 0.001) and 31–40 min (Effect –1.346 [95% CI: –
2.073, 0.619], P < 0.001), while no significant indirect
effect via intraoperative blood loss was demonstrated
(Fig. 4b).

Discussion
This study evaluated the prognostic impact of rWIT in
LT, which demonstrated that shortening rWIT within
Transplant International 2021;
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Table 3. Final model of multivariable Cox regression analysis with backward selection for risk factors for 1 and 5-year
graft loss.
1-year graft loss
Variable

P value HR

rWIT (ref. ≤ 30min)
31–40 min
0.02 2.20
41–50 min
0.02 2.30
50+ min
<0.001 3.70
CIT, per min increase
0.02 1.002
Recipient BMI (ref. 20–24.9)
25–30
0.46 1.22
>30
0.04 1.67
<20
0.53 0.63
Grade 3 or 4 encephalopathy
0.02 1.93
Karnofsky 10–30%
0.04 1.77
(ref. 40–100%)
MELD score at transplant
0.03 0.97
Primary liver disease
Acute liver failure
0.003 3.23
Hepatocellular carcinoma
–
–
Donor age
–
–
Donor gender female
0.02 1.53

5-year graft loss
95%CI Lower 95%CI Upper P value HR
1.11
1.14
1.82
1.000

4.36
4.67
7.53
1.004

0.01
0.03
0.001
0.057

0.72
1.02
0.15
1.12
1.02

2.05
2.72
2.68
3.33
3.09

0.95

0.997

1.48
–
–
1.08

7.05
–
–
2.16

1.76
1.64
2.25
1.001

95%CI Lower 95%CI Upper
1.15
1.05
1.41
1.000

2.70
2.57
3.59
1.002

–
–
–
–
–
–
0.001 1.81
–
–

–
–
–
1.26
–

–
–
–
2.60
–

–

–

–

1.001
1.13
1.01
–

3.70
1.92
1.02
–

–

0.050 1.93
0.005 1.47
<0.001 1.01
–
–

Variables for the final model were selected using a backward elimination method. Risks were adjusted for recipient factors (primary liver disease [ALD, hepatitis C, NASH, PSC, PBC, AIH, acute liver failure], presence of hepatocellular carcinoma, age, gender, race, BMI, diabetes, grade 3 or 4 encephalopathy, moderate to severe ascites, dialysis requirement, Karnofsky score,
MELD score, CIT, recipient WIT, surgical technique for hepatic vein reconstruction [piggyback/cavocavostomy vs bicaval techniques] and transplant year), and donor factors (donor age, race, gender, BMI).

Figure 3 Adjusted hazards of graft loss in the group of recipient warm ischemia time of 30 min or shorter according to cold ischemia.

30 min could improve post-LT outcomes. Notably, the
positive prognostic effects of short rWIT (≤30 min)
were more prominent when CIT exceeded 6 hours, suggesting that liver graft damage due to prolonged CIT
could be offset by a short rWIT. While the requirement
of intraoperative transfusion also decreased by shortening rWIT, there would be a concern that the prognostic
Transplant International 2021;
ª 2021 Steunstichting ESOT. Published by John Wiley & Sons Ltd

effects of short rWIT were the result of a smaller
amount of intraoperative blood transfusion, but not
necessarily directly causative of poor outcomes. In fact,
a larger amount of blood transfusion was significantly
associated with poor outcomes. It is unclear if prolonged rWIT caused more blood loss and transfusion,
which led to poorer outcomes or vice versa. To address
7
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Figure 4 Mediation Analysis evaluating the direct and indirect effects of recipient warm ischemia time on occurrence of a) graft loss and b)
early allograft dysfunction.
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this concern, we conducted mediation analysis to assess
the direct and indirect effects of rWIT on outcomes
associated with intraoperative blood transfusion. The
mediation analysis showed that rWIT had a significant
direct effect and an indirect effect via intraoperative
blood loss on graft outcomes. These results confirmed
that rWIT had a direct impact on the risk of graft loss
after LT, as well as an association with intraoperative
blood loss, which indirectly increased the risk of graft
loss. While the adverse effects of prolonged rWIT have
been well recognized, the novelty of this study is focusing on the positive prognostic impact of shorter rWIT,
compared to “acceptable rWIT of 30–50 min” and
“prolonged rWIT (>50 min)”. The results of this study
emphasize the potential of LT outcome improvement
by shortening rWIT within 30 min and reaffirm the
adverse impact of prolonged rWIT.
Short rWIT might enhance liver graft function immediately after reperfusion and quickly reverse intraoperative coagulopathy, which could lower intraoperative
blood loss and transfusion requirement. As hypothesized, there were significant trends of increasing requirement of blood transfusion as rWIT was prolonged.
However, we acknowledge that reasons for blood loss
and transfusion requirements during LT are multifactorial. Possible causes include severe preoperative coagulopathy, difficult hepatectomy, marginal donor liver
graft, and/or severe fibrinolysis. DCD-LT, retransplant,
or multi-organ transplant were excluded to homogenize
the study cohort and alleviate the concerns about technical difficulties, and donor quality. Of note, we were
unable to identify the exact period of blood loss and
transfusion requirement during each LT surgery, especially before or after reperfusion of the liver graft.
Therefore, it is difficult to draw a firm conclusion on
the association between short rWIT and a lower amount
of intraoperative blood transfusion. However, reports
from other groups have indicated the association
between ischemia-reperfusion injury of the liver graft
and intraoperative blood loss and transfusion, which
our results corroborate [12, 13]. Hence, the roles of
shorter rWIT in decreasing intraoperative blood loss
and transfusion should be emphasized.
Similarly, the occurrence of EAD after LT would be
multifactorial [14]. Many other studies have suggested
possible risk factors for EAD [15, 16]. Bastos-Neves
et al. reported that prolonged rWIT (40 min or longer)
was one of the risk factors [17]. In this study, recipient
and donor characteristics were adjusted to assess the
risk of rWIT for EAD. The risk adjustment model
showed that the risk of EAD was, compared to WIT of
Transplant International 2021;
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30 min or shorter, significantly higher in the groups of
rWIT of 41–50 min and >50min, and similar to the
groups of 31–40 min. EAD in LT is a well-known prognostic factor [18, 19]. Shortening rWIT may lead to a
decreased risk of EAD, which can improve short and
long-term graft and patient outcomes.
Another important finding of this study is the possible role of short rWIT in offsetting the risk of prolonged CIT. Cold ischemia time is also a well-known
prognostic factor in LT. In the liver donor risk index
formula, 8 hours was suggested as a cut-off associated
with worse outcomes [11]. In our series, CIT remained
as an independent risk factor for 1-year graft loss, and
CIT of 6 hours stratified the risk of liver graft loss
(Fig. S2). Because CIT and rWIT might have confounding and/or synergistic effects on outcomes, a subgroup
analysis was conducted by grouping patients according
to CIT to determine the prognostic effects of rWIT in
association with CIT. This subgroup analysis showed
that positive prognostic effects of short rWIT were more
evident in the prolonged CIT group. These findings
provide critical insight into donor and operative management. Transplant teams attempt to shorten CIT by
optimizing the timing and logistics of donor and recipient surgeries and liver graft transportation from a donor
hospital. However, there may be occasions when the
CIT is prolonged due to unexpected intraoperative findings or other reasons. It is worth acknowledging that
shortening rWIT could offset the adverse impact of prolonged CIT.
Reducing ischemia time, both CIT and rWIT is crucial
to maintain liver graft quality and improve LT outcomes
[20]. rWIT, reflective of the “time for liver graft implantation”, may be affected by surgical implantation techniques such as the piggyback and bicaval techniques. In
fact, the piggyback technique was significantly associated
with a short rWIT, compared to the bicaval technique.
Transplant centers may have their own preference, and,
in fact, our center preferentially selected the piggyback
technique, which was used in over 80% of LTs in this
series. It should be emphasized that the findings of this
study do not necessarily recommend the piggyback technique over the bicaval technique, because the technical
challenges and difficulties might bias the selection of the
hepatic vein reconstruction technique during LT. In our
series, the piggyback group had significantly better graft
survival compared to the bicaval group on univariable
analysis, but this did not remain as an independent factor by adjusting risk for other recipient and donor factors, including rWIT (Table 3). We analyzed the impact
of rWIT in the piggyback and bicaval groups separately.
9
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The effects of rWIT were significant in the piggyback
group, but not in the bicaval group (Data not shown).
However, this discrepancy might be due to the small
number of patients in the bicaval group. The pros and
cons of these techniques are beyond the scope of this
study. Instead, we emphasize the importance of avoiding
unnecessary extra time during the implantation. Sophistication and standardization of implantation techniques
are essential. Also, keys for successful implantation
include efficient teamwork with the operating room staff
and anesthesiologists. Preoperative briefing with the
operating room staff is crucial to let team members better understand the sequence of procedures and prepare
for necessary instruments, and devices required during
the surgery, especially during liver graft implantation.
During the implantation or immediately before the
reperfusion of the liver graft, patients may develop
hemodynamic instability and surgeons might need to
wait until this is optimized. Proactive optimization of the
hemodynamic state by experienced liver anesthesiologists
would avoid this holding time. There are occasional technical difficulties in the implantation because of lack of
abdominal space, recipient body habitus (deep abdominal
cavity), larger liver graft size relative to recipient body
size, portal vein thrombosis, and vessel tissue quality.
Interestingly, we did not observe significant differences in
rWIT according to the presence of portal vein thrombosis, donor BMI, recipient BMI, donor-recipient gender
match, or presence of ascites. The piggyback technique
was the only factor associated with short rWIT, compared to the bicaval technique. Optimal strategies to
shorten rWIT may include good preparation and exposure of the implantation field, and preoperative assessment of recipient and liver graft size match, allowing
consistent implantation procedures without significant
deviation. It may be beneficial for each transplant center
to re-explore the surgical techniques and strategies of
their procedures to consistently achieve short rWIT or at
least strive to avoid prolonged rWIT. Changing and
improving small details could lead to a significant time
difference. The message of this investigation is not that a
surgeon must hasten implantation time at all costs,
which could itself affect outcomes in a negative fashion.
Rather, this study emphasizes the impact of a short rWIT
on graft and recipient outcomes and encourages the surgeon and transplant center to modify implantation techniques, when possible and safe, to optimize these
outcomes.
This study is retrospective and performed at a single
center, limiting the generalizability of these findings in
other transplant centers. While one of the strengths of
10

this study is the large number of cases (over 1200 LTs
from our 20-year experience), the historical bias would
be another limitation. To alleviate this issue, the transplant year (era) was also included in the risk adjustment.
The prognostic effects of rWIT (liver implantation time)
and LT outcomes have been studied elsewhere. However,
the novelty of this study, which focused on the protective
impact of short rWIT, should be emphasized. Also, it
would be valuable and meaningful for transplant teams
to acknowledge the potential to mitigate the adverse
impact of prolonged CIT by shortening rWIT. It is difficult to prove the relationship between short rWIT, intraoperative blood loss, and transfusion requirements. The
presence of two different venous reconstructive techniques further adds to this complexity. That said, our
multivariate regression model did adjust for venous
reconstruction technique when analyzing graft and
patient survival. We further performed Mediation Analysis to demonstrate a direct relationship (irrespective of
blood loss) between rWIT and graft survival/EAD. In
addition, although the context of acute liver failure can
differ from that of other indications for liver transplantation, we decided to include this pathology in the study,
as it does constitute part of the spectrum of disease states
that are indications for liver transplantation within our
inclusion criteria. Acute liver failure was the indication
for transplant in only 32 patients (2.5%). We did adjust
for the etiology of liver disease in our multivariate analysis of graft and patient survival, so we believe that the
effect of this variable on our reported outcomes is minimal. Lastly, to homogenize the cohort, this study did not
include living donor LT, DCD-LT, retransplant, or combined organ transplants. Consequently, we are unable to
comment on the possible effects of rWIT in these cases.
However, there would be no reason for not seeing a similar positive impact of short rWIT in these cases.
In conclusion, this study revealed that keeping rWIT
within 30 min might decrease the risk of EAD and
improve short and long-term outcomes after LT. Protective effects of short rWIT were more prominent
when CIT exceeded 6 hours, which suggested that
shorter rWIT might offset the negative impact of prolonged CIT. Ischemic damage to the liver graft is one of
the biggest hurdles for successful LT, and many medical
and surgical strategies have been proposed to counteract
its effect. Because LT surgeries have been well standardized, we might think that there would not remain much
room for improvement in the liver graft implantation
techniques to shorten rWIT. However, it would be beneficial to revisit the basics of LT surgeries and explore
possibilities to shorten rWIT.
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